[Federal Register Volume 85, Number 10 (Wednesday, January 15, 2020)]
[Notices]
[Pages 2429-2430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00505]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. HHS-OS-2019-0015]
Solicitation for Public Comments on Questions From the National
Clinical Care Commission
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The National Clinical Care Commission (the Commission)
solicits public comments on a set of questions concerning the context,
policies, effectiveness, promising practices, and limitations and gaps
related to prevention and treatment of diabetes and its complications.
The Commission is charged to evaluate and make recommendations to the
Secretary of Health and Human Services (HHS) and Congress regarding
improvements to the coordination and leveraging of federal programs
related to awareness and clinical care for diabetes and its
complications. The set of questions is available in the SUPPLEMENTARY
INFORMATION section, below.
DATES: Electronic or written/paper comments will be accepted through
midnight Eastern Standard Time (EST) February 3, 2020.
ADDRESSES: Public comments can be submitted in the following ways:
Electronic submissions can be filed on the online docket
at http://www.regulations.gov by following the ``Instructions for
Public Comments'' section, below. Evidence and information supporting
your comments can be submitted as attachments. Comments submitted
electronically, including supporting attachments, will be posted to the
docket unchanged. Please provide your contact information or
organization name on the web-based form for potential follow up by the
Commission.
If you prefer to comment on paper, mail your comments to
the following address: Public Commentary, National Clinical Care
Commission, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852. For
mailed submissions, the Office of Disease Prevention and Health
Promotion will post your comments, as well as any attachments, to
http://www.regulations.gov.
Instructions for Public Comments: All electronic submissions must
be submitted in the Docket ID HHS-OS-2019-0015 for ``Solicitation for
Public Comments on Questions from the National Clinical Care
Commission.'' For access to the docket to provide and/or read all
comments received, go to https://www.regulations.gov and insert the
docket ID HHS-OS-2019-0015 into the search box and follow the prompts.
Comments are encouraged from the public and will be accepted
through February 3, 2020. The https://www.regulations.gov electronic
filing system will accept electronic comments until midnight Eastern
Standard Time at the end of February 3, 2020. Comments received by
mail/courier will be considered if they are postmarked or the delivery
service acceptance receipt date is on or before that date. Written
comments via mail will be uploaded into https://www.regulations.gov and
are under the same limitations as for those directly submitted
electronically into https://www.regulations.gov: 5,000-character limit
for text box, and maximum number (10) of attached files and maximum
size (10 MB) of each attached file.
FOR FURTHER INFORMATION CONTACT: Linda Harris, Designated Federal
Officer, National Clinical Care Commission, U.S. Department of Health
and Human Services, Office of the Assistant Secretary for Health,
Office of Disease Prevention and Health Promotion, 1101 Wootton
Parkway, Suite 420, Rockville, MD 20852. Email: [email protected].
SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act
(Pub. L. 115-80) requires the HHS Secretary to establish the National
Clinical Care Commission. The Commission consists of representatives of
specific federal agencies and non-federal individuals and entities who
represent diverse disciplines and views. The Commission will evaluate
and make recommendations to the HHS Secretary and Congress regarding
improvements to the coordination and leveraging of federal programs
related to awareness and clinical care for diabetes and its
complications.
The Commission invites members of the public to comment on any
issues or concerns they believe are relevant or appropriate to the
Commission's evaluation of federal programs. Specifically, the
Commission requests public comment on the following questions:
1. Context: What social, economic, and/or environmental factors
have the greatest impact on health care in general--and also on
prevention (Type 2) and/or management of diabetes (both Type 1 and Type
2)? What can be done by the federal government to address those social/
economic/environmental factors?
2. Policies: What policies should the federal government implement
to improve diabetes prevention and/or management? What is the evidence
to support those?
[[Page 2430]]
3. Effectiveness: What specific recommendations do you have for
federal agencies to be more effective and/or to collaborate better to
prevent and/or help manage diabetes? What is the basis for your
specific recommendations?
4. Promising Practices: What are the best and/or most promising
practices to prevent diabetes and/or to improve diabetes outcomes? What
is the evidence to support them?
5. Limitations and gaps: What are the greatest limitations or gaps
in federal programs to prevent diabetes and/or to improve diabetes
outcomes? What could the Federal government do to close the gaps? Are
there specific research needs? Are there specific research needs or
programs that would benefit from new or increased collaboration across
federal agencies?
Don Wright,
Deputy Assistant Secretary for Health, Disease Prevention and Health
Promotion.
[FR Doc. 2020-00505 Filed 1-14-20; 8:45 am]
BILLING CODE 4150-32-P